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Introduction
Innate immunity is critical in physiological
responses to pathogens, but can also
exacerbate diseases through proinflammatory signaling. Innate immune cells
rapidly generate high redox potential
reactive oxygen and nitrogen species
(RONS) as a host defense response.1
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In Vitro BLI assays:
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These RONS are key effector molecules in
inflammatory states, but excessive amounts
lead to oxidative stress in cells and disease
progression. Novel imaging approaches that
efficiently localize inflammation-induced
radical species would allow for precise
imaging of immuno-activation sites in vivo
that can be applied to study many
inflammatory diseases and guide therapeutic
choices.

Using imaging reporters to
detect innate immune
activity
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Bioluminescence Imaging (BLI):
Luminol and L-012 were used as
bioluminescence imaging substrates to be
oxidized by various key biological RONS
species found in living animals (Table 1).

Fig. 3: Images of L-012 bioluminescence
intensity of a) H2O2, HOCL, and singlet oxygen,
and b) NO and hydroxyl radical in vitro.

Time series over 1 hour:
Table 1. Reduction potentials of biologically
relevant redox-coupled reactions
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Fig. 5 The reduction potential of RONS species
showed a positive correlation versus the
bioluminescent flux of L-012 (r = 0.9429, p (two-tailed)
= 0.0167).
a) Individual points
b) Normalized to control (O2)

Conclusions
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L-012 time series
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has been
tested in pre-clinical studies as a Positron
Emission Tomography (PET) reporter for
imaging innate immunity activation in deep
tissues.
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➢ L-012 bioluminescent activity was shown to
strongly correlate with [18F]4FN retention.

Luminol time series

b)

Photonic reactivities in vitro of L-012 or
luminol (100 μM) with reactive oxygen and
nitrogen species (100 μM) were detected
through Bioluminescence Imaging (BLI).
Reactions were monitored dynamically
and quantified post-addition of various
RONS for 40 additional minutes by BLI.
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Fig. 2: In vivo arthritis model of inflammatory RONS
production: correlation of L-012 BLI with the novel
PET imaging reporter ([18F]4FN.
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➢ The bioluminescent emissions of these
substrates when oxidized render them
effective optical probes to localize superficial
sites of inflammation.
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➢ Luminol and L-012 are oxidized by RONS
found in biological immune systems.2,3
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Fig. 1: Antimicrobial mechanisms of

a)

The radiance of model bioluminescent
substrates positively correlated with the
standard reduction potential of RONS. This
property will help further quantitation of
current probes and potentially aid
development of new reporters for different
regimes of reactive oxygen/nitrogen
species.

Acknowledgements
Blank

40000

O2

30000

H2O2

20000

HOCL

10000

Singlet Oxygen

This presentation is supported by the National Cancer
Institute through the U54 CA096297/CA096300:
UPR/MDACC Partnership for Excellence in Cancer
Research Training Program.

•OH

0

NO

-10000
2

6

10 14 18 22 26 30 34 38

Time (min)

Fig. 4: Reactions with a) L-012 and b) Luminol
rapidly reached a steady state with modest
changes in photonic production rates for a few
RONS over one hour.
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